GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TTY Biopharm Co Ltd (ROCO:4105) » Definitions » 3-Year EPS without NRI Growth Rate

TTY Biopharm Co (ROCO:4105) 3-Year EPS without NRI Growth Rate : 6.90% (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is TTY Biopharm Co 3-Year EPS without NRI Growth Rate?

TTY Biopharm Co's EPS without NRI for the three months ended in Mar. 2024 was NT$1.09.

During the past 12 months, TTY Biopharm Co's average EPS without NRI Growth Rate was 5.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 6.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was -2.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 2.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of TTY Biopharm Co was 27.90% per year. The lowest was -16.90% per year. And the median was 12.50% per year.


Competitive Comparison of TTY Biopharm Co's 3-Year EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, TTY Biopharm Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TTY Biopharm Co's 3-Year EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TTY Biopharm Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where TTY Biopharm Co's 3-Year EPS without NRI Growth Rate falls into.



TTY Biopharm Co 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


TTY Biopharm Co  (ROCO:4105) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


TTY Biopharm Co 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of TTY Biopharm Co's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


TTY Biopharm Co (ROCO:4105) Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 3-1, Park Street, 3rd Floor, Nangang District, Taipei, TWN, 11503
TTY Biopharm Co Ltd is engaged in the manufacturing and marketing of pharmaceuticals and chemical drugs. The company's operating segment includes Oncology, Health Care, Anti-Infection, Domestic Cardiovascular and Gastrointestinal Drugs, and other segments. It generates maximum revenue from the Oncology segment. Geographically, it derives a majority of revenue from Taiwan and also has a presence in European and Other Countries. Some of its products include Algitab, Alginos, Sulfin, Metacin, Cepiro, Brosym, Colimycin, Cubicin, and others.

TTY Biopharm Co (ROCO:4105) Headlines

No Headlines